Work

Case report of secondary T-cell deficiency following the AstraZeneca COVID-19 vaccine

Year: 2024

Type: article

Abstract: We present a case of secondary T-cell deficiency particularly affecting CD4 T cells, along with the emergence of chronic spontaneous urticaria in a patient following COVID-19 vaccination. The condition was partially managed with omalizumab after initial first-line therapy proved ineffective.

Source: Journal of Allergy and Clinical Immunology Global

DOI: 10.1016/j.jacig.2024.100339

Authors: Amin Esmailian, Sara Laura Barnes, Marsus Pumar

Institutions: Monash University, Monash Health

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,000